Chairman of the Management Board of Volkswagen Group: Learning from Xiaopeng can catch up with China's speed
胡胡胡美丽_ss
发表于 2024-3-13 18:24:44
234
0
0
On March 13, at the 2024 media communication meeting of Volkswagen Group, Oliver Blume, Chairman of the Management Board of Volkswagen Group, stated that Volkswagen will adhere to the strategy of "in China, for China". Volkswagen's technology center in China will have over 3000 technical experts to better meet the needs of Chinese customers.
When it comes to cooperation with the new Chinese automaker Xiaopeng Motors, Obom stated that Volkswagen's collaboration with Xiaopeng can fill the gaps in the product line, and related new models will be launched in 2026. Through mutual learning with Xiaopeng Motors, "we have found that we can catch up with the development speed of China." Obemu said that Volkswagen will also develop cooperation with SAIC Group and launch new models in 2026.
Obom stated that Volkswagen values new energy vehicles and plans to launch 40 new models in the coming years, half of which are new energy vehicles.
CandyLake.com 系信息发布平台,仅提供信息存储空间服务。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
声明:该文观点仅代表作者本人,本文不代表CandyLake.com立场,且不构成建议,请谨慎对待。
猜你喜欢
- Starbucks China responds after 24 years of store lease ends! Fourth quarter revenue decreased by 7% year-on-year
- Most popular Chinese concept stocks fell on Monday, and the Nasdaq China Golden Dragon Index fell more than 2%
- Wal Mart stores in China are fully launched in Meituan
- Most popular Chinese concept stocks in the US stock market have risen, while the Nasdaq China Golden Dragon Index has risen by nearly 2%
- Eli Lilly's Alzheimer's disease therapy, Minolta (Donaimab Injection), has been approved in China
- Yum Brands China: The number of domestic stores with 30 Pizzahut products has reached 3606
- Honda and Nissan discuss merger, potentially becoming the world's third-largest automotive group
- Eli Lilly's Alzheimer's disease therapy, Minolta (Donaimab Injection), has been approved in China
- BeiGene ADC's new cancer drug BG-C137 has been clinically approved for the first time in China
- Popular Chinese concept stocks fluctuated on Friday, with the Nasdaq China Golden Dragon Index closing up 0.53%
-
隔夜株式市場 世界の主要指数は金曜日に多くが下落し、最新のインフレデータが減速の兆しを示したおかげで、米株3大指数は大幅に回復し、いずれも1%超上昇した。 金曜日に発表されたデータによると、米国の11月のPC ...
- SNT
- 前天 12:48
- 支持
- 反对
- 回复
- 收藏
-
長年にわたって、昔の消金大手の捷信消金の再編がようやく地に着いた。 天津銀行の発表によると、同行は京東傘下の2社、対外貿易信託などと捷信消金再編に参加する。再編が完了すると、京東の持ち株比率は65%に達し ...
- SNT
- 前天 12:09
- 支持
- 反对
- 回复
- 收藏
-
【GPT-5屋台で大きな問題:数億ドルを燃やした後、OpenAIは牛が吹くのが早いことを発見した】OpenAIのGPT-5プロジェクト(Orion)はすでに18カ月を超える準備をしており、関係者によると、このプロジェクトは現在進 ...
- SNT
- 3 小时前
- 支持
- 反对
- 回复
- 收藏
-
【ビットコインが飛び込む!32万人超の爆倉】データによると、過去24時間で世界には32万7000人以上の爆倉があり、爆倉の総額は10億ドルを超えた。
- 断翅小蝶腥
- 3 天前
- 支持
- 反对
- 回复
- 收藏